Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics?

Pharmacopsychiatry DOI: 10.1055/s-0043-122603The updated AGNP Consensus Guidelines for Therapeutic Drug Monitoring (TDM) in Neuropsychopharmacology recently published in the journal have reinforced the key role of TDM to individualize psychoparmacological therapies in clinical practice. However, we believe, that these guidelines have missed the important opportunity to face with, and to provide useful information on, the emerging issue of long-acting injectable formulations of atypical antipsychotics. Specific therapeutic ranges also for these formulations should be included in the next AGNP guidelines. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Pharmacopsychiatry - November 27, 2017 Category: Psychiatry Authors: Baldelli, Sara Clementi, Emilio Cattaneo, Dario Tags: Letter to the Editor Source Type: research